BMJ Open Impact Factor

The COVID-era spike to 4.4 in 2021 was driven by heavily cited pandemic-related research. BMJ Open published a large volume of COVID observational studies, many of which accumulated citations rapidly. The drop back to 2.3-2.4 represents a return to baseline, not a decline in journal quality.

The five-year JIF of 2.7 smooths over that spike and gives a more accurate picture. BMJ Open has been remarkably consistent in the 2.3-2.8 range outside the pandemic years.

BMJ Open accepts all study types across medicine. That's the official scope. In practice, what fills its pages tells you a lot about where your paper fits:

What gets published most frequently:

• Observational cohort and cross-sectional studies
• Systematic reviews and meta-analyses
• Study protocols (yes, they publish protocols before results exist)
• Qualitative research and mixed-methods studies
• Health services research and implementation science
• Public health and epidemiology studies

What's notable about this list: BMJ Open is one of the few indexed, respectable journals that actively welcomes study protocols and qualitative research. Most medical journals treat these as second-class submissions. BMJ Open treats them as legitimate contributions to the literature, and researchers in these areas know it.

What gets desk-rejected:

• Case reports (BMJ Open doesn't publish them; try BMJ Case Reports)
• Laboratory bench science without clinical relevance
• Studies with no ethics approval documentation
• Papers that don't follow reporting guidelines (STROBE, CONSORT, PRISMA)
• Manuscripts where the sample size doesn't support the conclusions

That last point is worth emphasizing. BMJ Open will publish small studies, but only if you're transparent about the limitations. A study with n=30 that claims generalizable results will get rejected. The same study framed as a pilot with appropriate caveats has a real shot.

BMJ Open pioneered fully open peer review in clinical medicine. Here's what that means in practice:

Every accepted paper gets its reviewer reports published alongside it. Not anonymized summaries. The actual reviewer comments, the editor's decision letters, and the authors' point-by-point responses. All of it, publicly accessible.

This has practical consequences for authors:

1. Reviewers write more carefully. Knowing their comments will be public tends to reduce dismissive or lazy reviews.
2. You can read reviews of similar papers. Before submitting, pull up a few accepted BMJ Open papers in your area and read the reviewer reports. You'll see exactly what editors and reviewers focused on.
3. Your revision quality matters publicly. A sloppy revision response will be visible to anyone who reads your paper. Treat it like a public document.

Reviewer names are published by default, though reviewers can opt out. About 60% choose to sign their reviews.

BMJ Open accepts roughly 45-50% of submitted manuscripts. That's relatively generous compared to selective journals, but the desk rejection rate is still meaningful. Papers without ethics documentation, without adherence to reporting guidelines, or with fundamental design flaws get caught early.

Typical timeline:

• Editorial assessment: 1-2 weeks
• Peer review: 4-8 weeks (2 reviewers standard)
• First decision: 6-10 weeks from submission
• Revision turnaround: 4-6 weeks (authors' side)
• Total submission to acceptance: 3-5 months

BMJ Open handles about 8,000-10,000 submissions per year and publishes around 3,500-4,000 papers. The volume means the editorial team is experienced at processing manuscripts efficiently, but it also means reviewers are sometimes stretched thin during peak submission periods (January-March and September-November).

BMJ Open charges $1,839 (GBP 1,600) as its article processing charge. That's mid-range for medical OA journals. For comparison, JAMA Network Open charges $3,000 and PLOS Medicine charges $5,300.

Fee waivers exist for corresponding authors from World Bank-classified low-income countries. Partial waivers can be negotiated for lower-middle-income countries. You need to request the waiver at submission, not after acceptance.

One thing to know: BMJ offers a Read and Publish agreement with many institutions. If your university has an agreement, the APC may be covered entirely. Check with your library before paying out of pocket.

Submit to BMJ Open if:

• You have a well-conducted observational study, protocol, or systematic review in clinical medicine
• You want transparent peer review with published reviewer reports
• You want indexing in PubMed, MEDLINE, Scopus, and Web of Science
• Your work is methodologically sound but doesn't aim for high novelty
• You're in public health, health services research, or implementation science
• You need a medical journal that takes qualitative research seriously

Think twice if:

• Your paper makes a novel clinical discovery (aim higher: BMJ, JAMA, Lancet)
• Impact factor matters a lot for your career stage (postdoc seeking faculty positions)
• Your study is basic science without direct clinical relevance
• You can't cover the $1,839 APC

For researchers in health services, public health, and primary care, BMJ Open is a workhorse journal. It's where you build a publication record with solid, rigorous clinical work. Nobody will raise an eyebrow at a BMJ Open publication on a CV. It's BMJ-branded, PubMed-indexed, and peer-reviewed.

For researchers in competitive biomedical fields targeting faculty positions at research-intensive institutions, the 2.3 impact factor may not carry enough weight. That's not a judgment on the journal. It's a reality of how hiring committees read CVs. In that situation, consider PLOS Medicine (IF 9.9) or JAMA Network Open (IF 13.8) if the work supports it.

One thing worth knowing: BMJ Open papers do get cited. The journal's h-index of 237 puts it ahead of many journals with higher impact factors. High-volume journals accumulate citations differently than selective ones, and individual BMJ Open papers regularly exceed 50 or 100 citations when the clinical question resonates.

BMJ Open's 2.3 impact factor is exactly what you'd expect from a high-volume, open access medical journal that publishes across all clinical disciplines. It's not trying to compete with The BMJ on selectivity or prestige. It's filling a different role: a transparent, rigorous, accessible home for clinical research that might otherwise sit in a drawer.

The transparent peer review model, reasonable APC, and genuine openness to study types that other journals won't touch (protocols, qualitative research, negative results) make it a practical option. If the work is sound and you don't need a flashy impact factor, BMJ Open delivers what it promises.

Preparing a clinical manuscript? Our AI manuscript diagnostic evaluates your paper's methodology, reporting compliance, and journal fit in about 30 minutes for $29.